Download PDF
Z Gastroenterol 2017; 55(03): 304-306
DOI: 10.1055/s-0042-120439
Kommentiertes Referat
© Georg Thieme Verlag KG Stuttgart · New York

Evolution des Designs klinischer Studien zur Untersuchung von Biologika-Therapien bei Patienten mit chronisch-entzündlichen Darmerkrankungen – Implikationen für die klinische Praxis

Evolution of clinical trial design investigating biological therapies in patients with inflammatory bowel disease – implications for clinical practice
Dominik Bettenworth
Further Information

Publication History

Publication Date:
05 December 2016 (online)

Also available at
    Permissions and Reprints

Ghosh S, Sandborn WJ, Colombel J-F, Feagan BG, Panaccione R, Hanauer S, Schreiber S, Peyrin-Biroulet L, Vermeire S, Eichner S, Huang B, Robinson AM, Pappalardo B. Interpreting registrational clincial trials of biological therapies in adults with inflammatory bowel disease. Inflammatory bowel disease 2016; ahead of print.

Danese S, Schabel E, Masure J, Plevy S, Schreiber S. Are we ready to abandon placebo in randomised clinical trials for inflammatory bowel disease? Pros and Cons J Crohn Colitis 2016; 10 (Suppl 2): S548 – 552